NCT05888610 is a NA clinical trial of Digital Outpost in Alzheimer's Disease, sponsored by Prepped Health LLC.

Who is sponsoring NCT05888610?

NCT05888610 is sponsored by Prepped Health LLC.

What drugs are being tested in NCT05888610?

Interventions in NCT05888610: Digital Outpost.

What condition does NCT05888610 study?

NCT05888610 studies Alzheimer's Disease, Dementia, Caregivers, Remote Monitoring.

Is NCT05888610 still recruiting?

NCT05888610 is currently completed. Last updated 29 November 2023.

Last reviewed 2023-11-29 · How we verify

NCT05888610

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Caregiver Solutions for Dementia Patients

Completed NA Last updated 29 November 2023

What this trial tests

NA trial testing Digital Outpost in Alzheimer's Disease in 10 participants. Completed in 12 July 2023.

Timeline

12 June 2023

Primary endpoint
12 July 2023

12 July 2023

Quick facts

Lead sponsor	Prepped Health LLC
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	10
Start date	12 June 2023
Primary completion	12 July 2023
Estimated completion	12 July 2023
Sites	1 location across United States

Drugs / interventions tested

Digital Outpost

Conditions studied

Alzheimer's Disease — all drugs for Alzheimer's Disease →
Dementia — all drugs for Dementia →
Caregivers — all drugs for Caregivers →
Remote Monitoring — all drugs for Remote Monitoring →

Sponsor

Prepped Health LLC

Who can join

Eligibility, any sex, with Alzheimer's Disease or Dementia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to test a mobile application amongst caregiver's supporting patients diagnosed with Alzheimer's Disease and Related Dementias (ADRD). The main question it aims to answer is: Will caregivers supporting patients diagnosed with ADRD utilize a mobile application to routinely report symptoms of the patients they care for?

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Alzheimer's Disease

Currently open trials in the same condition.

NCT07457138 — Lombard Cohort of Brain Health Services · recruiting
NCT07234942 — A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants Wit · Phase 1 · recruiting
NCT07479914 — Art of Memory for Cognitive Enhancement in the Monza Brain Health Service · NA · active not recruiting
NCT07214727 — A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease · Phase 1 · recruiting
NCT07105709 — Open-label Extension Study in Participants With Early Alzheimer's Disease · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05888610 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Prepped Health LLC
Last refreshed: 29 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05888610.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing